Advertisement

Progressive Apraxia of Speech and Primary Progressive Aphasias

  • Keith A. JosephsEmail author
  • Jennifer L. Whitwell
Chapter

Abstract

Apraxia of speech (AOS) is a motor disorder that occurs as a result of impairment in the planning or programming of movements for speech production. It is typically associated with cerebrovascular events, although it can also occur in the context of neurodegeneration where its importance has typically been deemphasized to “just a component of a presenting syndrome.” Primary progressive aphasia (PPA) is such a syndrome in which AOS coexists with other linguistic deficits, typically agrammatic aphasia. Recently, however, AOS has been demonstrated to occur in a pure or isolated form, known as primary progressive apraxia of speech (PPAOS), reaffirming the importance of neurodegenerative AOS. Furthermore, anatomic and pathologic associations differ between AOS-dominant syndromes and PPA variants. Understanding the relationship between AOS-dominant variants, including PPAOS and PPA, and their relationship to movement disorders including corticobasal degeneration and progressive supranuclear palsy, is important and will be the focus of this chapter.

Keywords

Apraxia of speech Primary progressive aphasia Tau Progressive supranuclear palsy Corticobasal degeneration Agrammatic aphasia 

References

  1. Acosta-Cabronero J, Patterson K, Fryer TD, Hodges JR, Pengas G, et al. Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story. Brain. 2012;134:2025–35.CrossRefGoogle Scholar
  2. Adeli A, Whitwell JL, Duffy JR, Strand EA, Josephs KA. Ideomotor apraxia in agrammatic and logopenic variants of primary progressive aphasia. J Neurol. 2013;260:1594–600.PubMedCrossRefGoogle Scholar
  3. Agosta F, Henry RG, Migliaccio R, Neuhaus J, Miller BL, et al. Language networks in semantic dementia. Brain. 2010;133:286–99.PubMedCentralPubMedCrossRefGoogle Scholar
  4. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496–503.PubMedCentralPubMedCrossRefGoogle Scholar
  5. Assal F, Laganaro M, Remund CD, Ragno Paquier C. Progressive crossed-apraxia of speech as a first manifestation of a probable corticobasal degeneration. Behav Neurol. 2012;25:285–9.PubMedCrossRefGoogle Scholar
  6. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135:765–83.PubMedCentralPubMedCrossRefGoogle Scholar
  7. Borroni B, Garibotto V, Agosti C, Brambati SM, Bellelli G, et al. White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol. 2008;65:796–801.PubMedCrossRefGoogle Scholar
  8. Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006;63:81–6.PubMedCrossRefGoogle Scholar
  9. Broussolle E, Tommasi M, Mauguiere F, Chazot G. Progressive anarthria with secondary parkinsonism: a clinico-pathological case report. J Neurol Neurosurg Psychiatry. 1992;55:577–80.PubMedCentralPubMedCrossRefGoogle Scholar
  10. Caselli RJ, Windebank AJ, Petersen RC, Komori T, Parisi JE, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993;33:200–7.PubMedCrossRefGoogle Scholar
  11. Caselli RJ, Beach TG, Sue LI, Connor DJ, Sabbagh MN. Dement Geriatr Cogn Disord. 2002;14:55–8.PubMedCrossRefGoogle Scholar
  12. Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Ann Neurol. 2001;49:433–42.PubMedCrossRefGoogle Scholar
  13. Chan D, Anderson V, Pijnenburg Y, Whitwell J, Barnes J, et al. The clinical profile of right temporal lobe atrophy. Brain. 2009;132:1287–98.PubMedCrossRefGoogle Scholar
  14. Coon EA, Sorenson EJ, Whitwell JL, Knopman DS, Josephs KA. Predicting survival in frontotemporal dementia with motor neuron disease. Neurology. 2011;76:1886–93.PubMedCentralPubMedCrossRefGoogle Scholar
  15. Czell D, Andersen PM, Neuwirth C, Morita M, Weber M. Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:138–40.PubMedCrossRefGoogle Scholar
  16. da Rocha AJ, Valerio BC, Buainain RP, Ferraz ME, da Silva CJ, et al. Motor neuron disease associated with non-fluent rapidly progressive aphasia: case report and review of the literature. Eur J Neurol. 2007;14:971–5.PubMedCrossRefGoogle Scholar
  17. Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. J Speech Hear Res. 1969;12:246–69.PubMedGoogle Scholar
  18. Darley FL, Aronson AE, Brown JR. Motor speech disorders. Philadelphia: W.B. Saunders; 1975.Google Scholar
  19. Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, et al. The pathological basis of semantic dementia. Brain. 2005;128:1984–95.PubMedCrossRefGoogle Scholar
  20. Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology. 2010;74:42–9.PubMedCrossRefGoogle Scholar
  21. Dickson DW. Neuropathology of Pick’s disease. Neurology. 2001;56:S16–20.PubMedCrossRefGoogle Scholar
  22. Dickson DW. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003.Google Scholar
  23. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002;61:935–46.PubMedGoogle Scholar
  24. Duffy J. Apraxia of speech in degenerative neurologic disease. Aphasiology. 2006;20:511–27.CrossRefGoogle Scholar
  25. Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. St Louis: Mosby; 2013.Google Scholar
  26. Duffy JR, Peach RK, Strand EA. Progressive apraxia of speech as a sign of motor neuron disease. Am J Speech Lang Pathol. 2007;16:198–208.PubMedCrossRefGoogle Scholar
  27. Edwards-Lee T, Miller BL, Benson DF, Cummings JL, Russell GL, et al. The temporal variant of frontotemporal dementia. Brain. 1997;120(Pt 6):1027–40.PubMedCrossRefGoogle Scholar
  28. Galantucci S, Tartaglia MC, Wilson SM, Henry ML, Filippi M, et al. White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain. 2011;134:3011–29.PubMedCentralPubMedCrossRefGoogle Scholar
  29. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain. 2000;123(Pt 3):484–98.PubMedCrossRefGoogle Scholar
  30. Galton CJ, Patterson K, Graham K, Lambon-Ralph MA, Williams G, et al. Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia. Neurology. 2001;57:216–25.PubMedCrossRefGoogle Scholar
  31. Ghetti B, Hutton M, Wszolek Z. Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17T). In: Dickson D, editor. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003. p. 86–102.Google Scholar
  32. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55:335–46.PubMedCentralPubMedCrossRefGoogle Scholar
  33. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.PubMedCentralPubMedCrossRefGoogle Scholar
  34. Graff-Radford NR, Damasio AR, Hyman BT, Hart MN, Tranel D, et al. Progressive aphasia in a patient with Pick’s disease: a neuropsychological, radiologic, and anatomic study. Neurology. 1990;40:620–6.PubMedCrossRefGoogle Scholar
  35. Graff-Radford J, Duffy JR, Strand EA, Josephs KA. Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia. Parkinsonism Relat Disord. 2012;18:890–2.PubMedCentralPubMedCrossRefGoogle Scholar
  36. Greene JD, Patterson K, Xuereb J, Hodges JR. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol. 1996;53:1072–8.PubMedCrossRefGoogle Scholar
  37. Groschel K, Hauser TK, Luft A, Patronas N, Dichgans J, et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage. 2004;21:714–24.PubMedCrossRefGoogle Scholar
  38. Grossman M, McMillan C, Moore P, Ding L, Glosser G, et al. What’s in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer’s disease, frontotemporal dementia and corticobasal degeneration. Brain. 2004;127:628–49.PubMedCrossRefGoogle Scholar
  39. Grossman M, Powers J, Ash S, McMillan C, Burkholder L, et al. Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology. Brain Lang. 2013;127:106–20.PubMedCrossRefGoogle Scholar
  40. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44:2015–9.PubMedCrossRefGoogle Scholar
  41. Hodges JR, Patterson K. Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol. 2007;6:1004–14.PubMedCrossRefGoogle Scholar
  42. Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56:399–406.PubMedCrossRefGoogle Scholar
  43. Huey ED, Pardini M, Cavanagh A, Wassermann EM, Kapogiannis D, et al. Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndrome. Arch Neurol. 2009;66:1274–80.PubMedCentralPubMedCrossRefGoogle Scholar
  44. Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol. 2008;21:688–92.PubMedCrossRefGoogle Scholar
  45. Josephs KA, Boeve BF, Duffy JR, Smith GE, Knopman DS, et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005;11:283–96.PubMedCrossRefGoogle Scholar
  46. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006a;129:1385–98.PubMedCentralPubMedCrossRefGoogle Scholar
  47. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006b;66:41–8.PubMedCrossRefGoogle Scholar
  48. Josephs KA, Whitwell JL, Dickson DW, Boeve BF, Knopman DS, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging. 2008;29:280–9.PubMedCentralPubMedCrossRefGoogle Scholar
  49. Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology. 2009a;73:1443–50.PubMedCentralPubMedCrossRefGoogle Scholar
  50. Josephs KA, Stroh A, Dugger B, Dickson DW. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol. 2009b;118:349–58.PubMedCentralPubMedCrossRefGoogle Scholar
  51. Josephs KA, Duffy JR, Fossett TR, Strand EA, Claassen DO, et al. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol. 2010;67:596–605.PubMedCrossRefGoogle Scholar
  52. Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137–53.PubMedCentralPubMedCrossRefGoogle Scholar
  53. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. 2012;135:1522–36.PubMedCentralPubMedCrossRefGoogle Scholar
  54. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, et al. Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology. 2013a;81:337–45.PubMedCrossRefGoogle Scholar
  55. Josephs KA, Whitwell JL, Murray ME, Parisi JE, Graff-Radford NR, et al. Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. Brain. 2013b;136:455–70.PubMedCentralPubMedCrossRefGoogle Scholar
  56. Kelley BJ, Haidar W, Boeve BF, Baker M, Graff-Radford NR, et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging. 2009;30:739–51.PubMedCentralPubMedCrossRefGoogle Scholar
  57. Kertesz A, Hudson L, Mackenzie IR, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology. 1994;44:2065–72.PubMedCrossRefGoogle Scholar
  58. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128:1996–2005.PubMedCrossRefGoogle Scholar
  59. Knake S, Belke M, Menzler K, Pilatus U, Eggert KM, et al. In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord. 2010;25:1232–8.PubMedCrossRefGoogle Scholar
  60. Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59:156–65.PubMedCrossRefGoogle Scholar
  61. Knopman DS, Mastri AR, Frey 2nd WH, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology. 1990;40:251–6.PubMedCrossRefGoogle Scholar
  62. Koyama M, Yagishita A, Nakata Y, Hayashi M, Bandoh M, et al. Imaging of corticobasal degeneration syndrome. Neuroradiology. 2007;49:905–12.PubMedCrossRefGoogle Scholar
  63. Kremen SA, Mendez MF, Tsai P, Teng E. Extrapyramidal signs in the primary progressive aphasias. Am J Alzheimers Dis Other Demen. 2011;26:72–7.PubMedCentralPubMedCrossRefGoogle Scholar
  64. Lang AE. Cortical basal ganglionic degeneration presenting with “progressive loss of speech output and orofacial dyspraxia”. J Neurol Neurosurg Psychiatry. 1992;55:1101.PubMedCentralPubMedCrossRefGoogle Scholar
  65. Lippa CF, Cohen R, Smith TW, Drachman DA. Primary progressive aphasia with focal neuronal achromasia. Neurology. 1991;41:882–6.PubMedCrossRefGoogle Scholar
  66. Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (Berl). 2006;112:539–49.CrossRefGoogle Scholar
  67. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122:111–3.PubMedCentralPubMedCrossRefGoogle Scholar
  68. Madhavan A, Whitwell JL, Weigand SD, Duffy JR, Strand EA, et al. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer’s type. PLoS One. 2013;8:e62471.PubMedCentralPubMedCrossRefGoogle Scholar
  69. Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135:736–50.PubMedCentralPubMedCrossRefGoogle Scholar
  70. Mahoney CJ, Malone IB, Ridgway GR, Buckley AH, Downey LE, et al. White matter tract signatures of the progressive aphasias. Neurobiol Aging. 2013;34:1687–99.PubMedCentralPubMedCrossRefGoogle Scholar
  71. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11:592–8.PubMedCrossRefGoogle Scholar
  72. Mesulam MM. Primary progressive aphasia. Ann Neurol. 2001;49:425–32.PubMedCrossRefGoogle Scholar
  73. Mesulam MM. Primary progressive aphasia–a language-based dementia. N Engl J Med. 2003;349:1535–42.PubMedCrossRefGoogle Scholar
  74. Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007;64:43–7.PubMedCrossRefGoogle Scholar
  75. Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008;63:709–19.PubMedCentralPubMedCrossRefGoogle Scholar
  76. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006;60:314–22.PubMedCentralPubMedCrossRefGoogle Scholar
  77. Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, et al. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol. 2000;47:36–45.PubMedCrossRefGoogle Scholar
  78. Ogar J, Slama H, Dronkers N, Amici S, Gorno-Tempini ML. Apraxia of speech: an overview. Neurocase. 2005;11:427–32.PubMedCrossRefGoogle Scholar
  79. Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131:721–31.PubMedCrossRefGoogle Scholar
  80. Ridgway GR, Lehmann M, Barnes J, Rohrer JD, Warren JD, et al. Early-onset alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology. 2012;79:80–4.Google Scholar
  81. Roh JH, Suh MK, Kim EJ, Go SM, Na DL, Seo SW. Glucose metabolism in progressive nonfluent aphasia with and without parkinsonism. Neurology. 2010;75:1022–4.PubMedCrossRefGoogle Scholar
  82. Rohrer JD, Warren JD, Modat M, Ridgway GR, Douiri A, et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology. 2009;72:1562–9.PubMedCentralPubMedCrossRefGoogle Scholar
  83. Rohrer JD, Crutch SJ, Warrington EK, Warren JD. Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia. 2010;48:288–97.PubMedCentralPubMedCrossRefGoogle Scholar
  84. Schwindt GC, Graham NL, Rochon E, Tang-Wai DF, Lobaugh NJ, et al. Whole-brain white matter disruption in semantic and nonfluent variants of primary progressive aphasia. Hum Brain Mapp. 2013;34:973–84.PubMedCrossRefGoogle Scholar
  85. Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135:723–35.PubMedCrossRefGoogle Scholar
  86. Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129:3091–102.PubMedCrossRefGoogle Scholar
  87. Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007;114:31–8.PubMedCrossRefGoogle Scholar
  88. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135:693–708.PubMedCentralPubMedCrossRefGoogle Scholar
  89. Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology. 1999;53:502–7.PubMedCrossRefGoogle Scholar
  90. Thompson SA, Patterson K, Hodges JR. Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology. 2003;61:1196–203.PubMedCrossRefGoogle Scholar
  91. Warrington E. Selective impairment of semantic memory. Q J Exp Psychol. 1975;27:635–57.PubMedCrossRefGoogle Scholar
  92. Wechsler AF, Verity MA, Rosenschein S, Fried I, Scheibel AB. Pick’s disease. A clinical, computed tomographic, and histologic study with golgi impregnation observations. Arch Neurol. 1982;39:287–90.PubMedCrossRefGoogle Scholar
  93. Whitwell JL, Avula R, Senjem ML, Kantarci K, Weigand SD, et al. Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology. 2010a;74:1279–87.PubMedCentralPubMedCrossRefGoogle Scholar
  94. Whitwell JL, Jack Jr CR, Boeve BF, Parisi JE, Ahlskog JE, et al. Imaging correlates of pathology in corticobasal syndrome. Neurology. 2010b;75:1879–87.PubMedCentralPubMedCrossRefGoogle Scholar
  95. Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, et al. Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol. 2011;68:753–60.PubMedCentralPubMedCrossRefGoogle Scholar
  96. Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML, et al. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol. 2013a;20:629–37.PubMedCrossRefGoogle Scholar
  97. Whitwell JL, Duffy JR, Strand EA, Xia R, Mandrekar J, et al. Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang. 2013b;125:245–52.PubMedCrossRefGoogle Scholar
  98. Zhang Y, Schuff N, Du AT, Rosen HJ, Kramer JH, et al. White matter damage in frontotemporal dementia and Alzheimer’s disease measured by diffusion MRI. Brain. 2009;132:2579–92.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of NeurologyMayo ClinicRochesterUSA
  2. 2.Department of RadiologyMayo ClinicRochesterUSA

Personalised recommendations